The Fort Worth Press

Bear Robotics' Carti 100 Wins iF DESIGN AWARD 2025, Setting New Standards in Logistics Automation

REDWOOD CITY, CA / ACCESS Newswire / March 11, 2025 / Bear Robotics is thrilled to announce that its Carti 100 autonomous mobile robot has been awarded the prestigious iF DESIGN AWARD 2025 in the Product category, Robotics discipline. This achievement reinforces Bear Robotics' position as a leader in innovative robotic design for logistics, building upon the success of the Servi Plus award earlier last year.

ACCESS Newswire Inc. to Host Fourth Quarter and FY 2024 Earnings Conference Call on March 25, 2025

RALEIGH, NORTH CAROLINA / ACCESS Newswire / March 11, 2025 / ACCESS Newswire Inc. (NYSE American:ACCS), an industry-leading communications company, today announced it will host a conference call and live webcast on March 25, 2025 at 9:00am Eastern Time to discuss the results of the fourth quarter and full year ended 2024.

1606 Corp. Signs LOI to Be Acquired by Private Group Seeking to Enter the Public Markets and Utilize AI Technologies for Potential Uplisting

SEATTLE, WASHINGTON / ACCESS Newswire / March 11, 2025 / (OTC Pink:CBDW), a pioneer in AI-powered IR, is pleased to announce that it has signed a non-binding Letter of Intent (LOI) with a private group led by Jon Garfield and Chuck Arnold which is focused on acquiring waste management companies, to acquire a controlling position in the Company for $1 million. This agreement marks a significant milestone for 1606 Corp. as the group moves to acquire a controlling position in the Company for $1 million, with consideration specifics to be negotiated at a later date in definitive agreements. It is anticipated that key management within 1606 Corp. will remain with the Company post-acquisition.

TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D., Former Vice President, Oncology Clinical Development, Diagnostics, and Global Medical Affairs, Johnson & Johnson Innovative Medicine Research & Development, to its Board of Directors

Dr. Tendler oversaw 30 Major Drug Approvals, including worldwide approvals for J&J's transformational treatments in hematologic malignancies, prostate, lung and bladder cancersDr. Tendler also oversaw 13 FDA Breakthrough Designations accelerating the early development of promising investigational medicines intended for treatment of serious oncology indications

Russian disinformation 'infects' AI chatbots, researchers warn

A sprawling Russian disinformation network is manipulating Western AI chatbots to spew pro-Kremlin propaganda, researchers say, at a time when the United States is reported to have paused its cyber operations against Moscow.

TaxBandits Now Supports IRS E-Filing For Forms 1099-QA and 1098-F

TaxBandits has expanded its e-filing services to include IRS Forms 1099-QA and 1098-F, offering a streamlined and secure solution for businesses and tax professionals.

Avant Technologies and JV Partner, Ainnova, Strategically Align with Apollo Hospitals to Advance AI in Healthcare

LAS VEGAS, NV / ACCESS Newswire / March 10, 2025 / Avant Technologies Inc. (OTCQB:AVAI) ("Avant" or the "Company"), and its partner, Ainnova Tech, Inc., (Ainnova), a leading healthcare technology company focused on revolutionizing early disease detection using artificial intelligence (AI), today announced that Apollo Hospitals (Apollo) and Ainnova have officially established a strategic collaboration that marks a significant step forward in the integration of artificial intelligence into disease detection and prediction.

TuHURA Biosciences, Inc. to Present at the 37th Annual ROTH Conference

Live webcast fireside chat on Tuesday, March 18th at 8:30 AM PT

'So important': Selma marks 60 years since US civil rights march

Hundreds gathered Sunday in Selma, Alabama to mark the 60th anniversary of "Bloody Sunday," when a group of peaceful demonstrators marched for African Americans' voting rights and were brutally beaten by police.

Oops, we tipped it again: Mission over for sideways US lander

Intuitive Machines' second Moon mission ended in disappointment on Friday after the US company confirmed that its spacecraft had tipped over and was unable to recharge its solar-powered batteries -- mirroring its first attempt last year.

Oops, we tipped it again: Mission over for private US lander

Intuitive Machines' second Moon mission ended in disappointment Friday after its spacecraft tipped over and was left unable to recharge its solar-powered batteries, mirroring the US company's first attempt last year.

Mission over for private US lander after wonky landing

Intuitive Machines' second Moon mission ended in disappointment Friday after its spacecraft tipped over and was left unable to recharge its solar-powered batteries, mirroring the US company's first attempt last year.

US company says Moon mission over after landing sideways again

A private company's second attempt to land on the Moon officially ended Friday after its Athena spaceship came down sideways in a repeat of an off-kilter landing last year.

Musk's SpaceX faces new Starship setback

Elon Musk's SpaceX on Thursday once again lost the upper stage of its massive Starship rocket in a fiery explosion, even as the booster was successfully caught in its latest orbital test -- a near replay of the previous attempt.

Musk's SpaceX faces setback with new Starship upper stage loss

Elon Musk's SpaceX saw mixed results in the latest test launch of its Starship mega-rocket Thursday, successfully catching the massive booster but with the upper stage failing for the second consecutive time.

Deja vu on the Moon: Private US spaceship again lands awkwardly

Second time unlucky: A US company's lunar lander appears to have touched down at a wonky angle on Thursday, an embarrassing repeat of its previous mission's less-than-perfect landing last year.

Private US spaceship lands near Moon's south pole in uncertain condition

A US company's spaceship touched down on the Moon on Thursday, but its condition -- including whether it landed upright -- remains uncertain.

SpaceX gears up for Starship launch as Musk controversy swirls

SpaceX prepared for the next test flight of its massive Starship prototype rocket Thursday, as scrutiny grows over founder Elon Musk's influence on the US government's space program.

SpaceX gearing up for Starship launch amid Musk controversy

SpaceX is preparing for the next test flight of its massive Starship prototype rocket, as debate swirls over founder Elon Musk's influence on the US government's space program.

US firm hours away from Moon landing with drill, rovers, drone

A drill for ice, a 4G network test, three rovers, and a hopping drone: a US company is hours away from its second lunar landing attempt on Thursday, aiming to advance technologies for future human missions.

US firm targets Moon landing with drill, rovers, hopping drone

A drill to search for ice. A 4G network test. Three rovers and a first-of-its-kind hopping drone.

Unusual Machines to Participate in the 37th Annual ROTH Conference

ORLANDO, FLORIDA / ACCESS Newswire / March 6, 2025 / Unusual Machines (NYSE AMERICAN:UMAC), a leading provider of NDAA-compliant drone components, today announced its participation in the 37th Annual Roth Conference to be held Sunday, March 16th to Tuesday, March 18th at the Laguna Cliffs Marriott Resort & Spa in Dana Point, California.

Variphy Introduces CUBE CDR Reporting and Analytics in Variphy Cloud for Greater Granularity

LAFAYETTE, CA / ACCESS Newswire / March 6, 2025 / Variphy, a leader in Unified Communications (UC) reporting and analytics, has announced the launch of CUBE CDR analytics in Variphy Cloud, bringing advanced call data reporting, traffic analysis, and enhanced data visualization to cloud environments.

tZERO Sets the Date for the Full Tokenization of TZROP

TZROP will be Fully Tokenized on March 14, 2025 and will Become the First Digital Asset Security to be Supported by tZERO's Special Purpose Broker Dealer Digital Custody Services

SpaceX aims for Thursday Starship test flight

Elon Musk's SpaceX is now aiming for Thursday to conduct the next test flight of its massive Starship rocket, following a last-minute cancellation on Monday.

SpaceX aims for Wednesday Starship test flight after last-minute scrub

Elon Musk's SpaceX is now aiming for Wednesday to conduct the next test flight of its massive Starship rocket, following a last-minute cancellation on Monday.

Bedrock and SPINS Partner to Drive Wellness-Focused CPG Insights

OAKLAND, CA / ACCESS Newswire / March 5, 2025 / Bedrock Analytics, a leading provider of cloud-based data analytics, is excited to announce a strategic partnership with SPINS, a leading provider of wellness-focused data, analytics, and insights for the consumer-packaged goods (CPG) industry.

'Stranded' NASA astronaut backs Musk in rescue row

NASA astronaut Butch Wilmore, stranded on the International Space Station since June, said Tuesday he believes Elon Musk's claim that the billionaire proposed an early rescue plan, but it was ultimately rejected by then-President Joe Biden.

SpaceX calls off Starship test flight at last minute

Elon Musk's SpaceX called off the latest test flight of its Starship rocket just before its scheduled launch on Monday, citing an unspecified problem with the behemoth spacecraft.

Tharimmune Announces Positive Target Engagement with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick Technology

BRIDGEWATER, NJ / ACCESS Newswire / March 4, 2025 / Tharimmune, Inc. (NASDAQ:THAR) ("Tharimmune" or the "Company"), a clinical-stage biotechnology company focused on immunology and inflammation, today announced the expansion of its product pipeline with HS1940, a dual-target multispecific biologic engineered to bind to both Programmed Death-1 (PD-1) and Vascular Endothelial Growth Factor (VEGF) receptors. Using its proprietary EpiClick™ Technology, a versatile multispecific antibody engineering platform, HS1940 represents a key expansion of Tharimmune's product pipeline and underscores the Company's commitment to addressing unmet needs.

Micreos Pharmaceuticals Partners With Biologics CDMO Northway Biotech for Its Engineered Endolysin Therapeutic Manufacturing Program

Micreos is focused on developing best-in-class targeted therapeutics to precisely target harmful pathogens that cause disease flares to help address significant unmet medical needs in dermatology and oncology.

GA-ASI Flies Government Reference Autonomy Stack at Orange Flag 25-1

Government-Supplied Pilot Vehicle Interface Used for Unmanned Combat Air Vehicles

The Fort Worth Press - Technology (English)

Featured

Cesar Chavez, icon of US labor movement, accused of serial sex abuse: report

Modulate Launches Velma Transcribe: High-Performance Transcription For Real World Conversations at 90% Lower Cost

Last news